Thomas 2008.
Methods | Twelve‐week, multi‐centred randomised controlled trial. |
Participants | Patients with depression according to ICD‐10 criteria, recruited in primary care setting. |
Interventions | Citalopram dose range: 20 mg/day. Reboxetine dose range: 8 mg/day. |
Outcomes | Change in Beck Depression Inventory (BDI) from baseline to week 6. |
Notes | Only study protocol available. |